Apotex expected to fetch $10-billion valuation as drugmaker files to go public on TSX
- Posted on May 28, 2026
- By The Globe and Mail
- 0 Views
- 1 min read
Apotex expected to fetch $10-billion valuation as drugmaker files to go public on TSX
Toronto company founded by the late Barry Sherman expected to become Canada’s most valuable public life sciences company
